Delivery Order SPE2DB22D9143-SPE2DB24FZB29
Award Date 1/31/24
Potential Completion Date 2/22/24
Potential Value $28K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 MG/ML SYRINGE. The single-award, firm fixed-price contract has a ceiling value of $37,137.60 and an ultimate completion date of May 3, 2024. This delivery order is placed under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the DLA, which has a total potential value of up to $4,999,999 through 2025. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 MG/ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $7,737.00 and a period of performance through April 5, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery vehicle (IDV) contract, #4600082013 under the SPE2DB program, with DLA valued at up to $4,999,999 through the end of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML and has an ultimate completion date of April 30, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, valued up to $4,999,999, that enables DLA to procure a broad range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, number SPE2DB24FZB70, to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGEML. The $18,568.80 order has an ultimate completion date of April 16, 2024. This delivery order is part of a larger indefinite delivery contract, number SPE2DB22D9143, that DMS Pharmaceutical Group holds with DLA, valued at up to $4,999,999 through the end of 2025. The IDC enables DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, with a completion date of March 13, 2024 and a potential value of $6,189.60. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the...
- This is a delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The order is for XOLAIR 150 MG/ML SYRINGE, with a firm fixed price of $13,926.60 and a completion date of February 20, 2024. The order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency, a single-award vehicle valued up to $4,999,999 through 2025 that enables the DLA to issue...
- This is a delivery order contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract is for $4,642.20 to provide XOLAIR 150 MG/ML syringes. This order is part of a larger indefinite delivery vehicle (IDV) contract #4600082013 with DMS Pharmaceutical Group Inc. valued at up to $4,999,999 through 2025, under which DLA can place firm fixed-price delivery orders for a broad range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the supply of XOLAIR 150 MG/ML SYRINGEML. The contract has a firm fixed-price pricing type and a potential value of $46,422.00. It does not have a set-aside designation. The contract is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, that DMS Pharmaceutical Group Inc. holds with the DLA. This...
- This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, involves the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The single-award, firm-fixed-price contract has a ceiling value of $10,058.10 and runs through April 17, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, valued up to $4,999,999, that DMS Pharmaceutical Group holds with the DLA. The IDV enables the DLA to issue delivery orders for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of Xolair 150 mg/mL syringes, with a potential value of $37,137.60 and a completion date of January 12, 2024. The delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA, valued up to $5 million through December 2025, to provide a variety of pharmaceutical items...